Sapience Therapeutics, Inc., a clinical-stage biotechnology company focused on the discovery and development of peptide therapeutics to address oncogenic and immune dysregulation that drive cancer, today announced its participation in the Jefferies Global Healthcare Conference taking place June 3-5, 2025, in New York.
Members of the Company’s management team will be available for one-on-one meetings on Tuesday, June 3, 2025.
